nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—Lisinopril—dilated cardiomyopathy	0.36	1	CrCtD
Enalapril—ACE—dilated cardiomyopathy	0.139	1	CbGaD
Enalapril—ACE—Lisinopril—dilated cardiomyopathy	0.0889	0.448	CbGbCtD
Enalapril—Fosinopril—Lisinopril—dilated cardiomyopathy	0.0387	0.158	CrCrCtD
Enalapril—SLC15A1—Lisinopril—dilated cardiomyopathy	0.0356	0.18	CbGbCtD
Enalapril—Moexipril—Lisinopril—dilated cardiomyopathy	0.0291	0.119	CrCrCtD
Enalapril—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.0285	0.144	CbGbCtD
Enalapril—Spirapril—Lisinopril—dilated cardiomyopathy	0.0251	0.103	CrCrCtD
Enalapril—Cilazapril—Lisinopril—dilated cardiomyopathy	0.0251	0.103	CrCrCtD
Enalapril—Ramipril—Lisinopril—dilated cardiomyopathy	0.0236	0.0962	CrCrCtD
Enalapril—Trandolapril—Lisinopril—dilated cardiomyopathy	0.0236	0.0962	CrCrCtD
Enalapril—Nateglinide—Lisinopril—dilated cardiomyopathy	0.021	0.0858	CrCrCtD
Enalapril—Aspartame—Lisinopril—dilated cardiomyopathy	0.02	0.0814	CrCrCtD
Enalapril—Quinapril—Lisinopril—dilated cardiomyopathy	0.02	0.0814	CrCrCtD
Enalapril—Benazepril—Lisinopril—dilated cardiomyopathy	0.019	0.0776	CrCrCtD
Enalapril—SLC22A8—Furosemide—dilated cardiomyopathy	0.017	0.0856	CbGbCtD
Enalapril—SLC22A6—Furosemide—dilated cardiomyopathy	0.0118	0.0596	CbGbCtD
Enalapril—ABCB1—Lisinopril—dilated cardiomyopathy	0.00875	0.0441	CbGbCtD
Enalapril—ABCB1—Spironolactone—dilated cardiomyopathy	0.0077	0.0389	CbGbCtD
Enalapril—Knee pain—Lisinopril—dilated cardiomyopathy	0.00191	0.0433	CcSEcCtD
Enalapril—ACE—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00148	0.164	CbGpPWpGaD
Enalapril—ACE—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.00115	0.127	CbGpPWpGaD
Enalapril—Pain in arm—Lisinopril—dilated cardiomyopathy	0.0011	0.0248	CcSEcCtD
Enalapril—Pulmonary eosinophilia—Lisinopril—dilated cardiomyopathy	0.000984	0.0223	CcSEcCtD
Enalapril—Acute myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000984	0.0223	CcSEcCtD
Enalapril—Pemphigus—Lisinopril—dilated cardiomyopathy	0.000938	0.0213	CcSEcCtD
Enalapril—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.000877	0.0969	CbGpPWpGaD
Enalapril—ACE—pulmonary artery—dilated cardiomyopathy	0.000814	0.374	CbGeAlD
Enalapril—ACE—sympathetic nervous system—dilated cardiomyopathy	0.000792	0.363	CbGeAlD
Enalapril—Antinuclear antibody positive—Lisinopril—dilated cardiomyopathy	0.000792	0.018	CcSEcCtD
Enalapril—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.000737	0.0814	CbGpPWpGaD
Enalapril—Red blood cell sedimentation rate increased—Lisinopril—dilated cardiomyopathy	0.000667	0.0151	CcSEcCtD
Enalapril—Shoulder pain—Lisinopril—dilated cardiomyopathy	0.000667	0.0151	CcSEcCtD
Enalapril—Infarction—Lisinopril—dilated cardiomyopathy	0.000648	0.0147	CcSEcCtD
Enalapril—ACE—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.000623	0.0688	CbGpPWpGaD
Enalapril—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.000615	0.0679	CbGpPWpGaD
Enalapril—ACE—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.000479	0.0529	CbGpPWpGaD
Enalapril—Vasculitis—Spironolactone—dilated cardiomyopathy	0.000451	0.0102	CcSEcCtD
Enalapril—Flank pain—Lisinopril—dilated cardiomyopathy	0.000446	0.0101	CcSEcCtD
Enalapril—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.000433	0.00982	CcSEcCtD
Enalapril—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.000416	0.00943	CcSEcCtD
Enalapril—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.000394	0.00894	CcSEcCtD
Enalapril—Leg pain—Lisinopril—dilated cardiomyopathy	0.000389	0.00883	CcSEcCtD
Enalapril—Lung infiltration—Lisinopril—dilated cardiomyopathy	0.000383	0.0087	CcSEcCtD
Enalapril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—dilated cardiomyopathy	0.000354	0.0391	CbGpPWpGaD
Enalapril—ACE—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.000337	0.0373	CbGpPWpGaD
Enalapril—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.000309	0.00702	CcSEcCtD
Enalapril—Ataxia—Spironolactone—dilated cardiomyopathy	0.000301	0.00682	CcSEcCtD
Enalapril—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.000292	0.00663	CcSEcCtD
Enalapril—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000288	0.00653	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000288	0.00653	CcSEcCtD
Enalapril—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.00028	0.00635	CcSEcCtD
Enalapril—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000274	0.00621	CcSEcCtD
Enalapril—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000273	0.00619	CcSEcCtD
Enalapril—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.000266	0.00604	CcSEcCtD
Enalapril—Drug interaction—Furosemide—dilated cardiomyopathy	0.000258	0.00586	CcSEcCtD
Enalapril—Captopril—ACE—dilated cardiomyopathy	0.000257	0.146	CrCbGaD
Enalapril—Gout—Furosemide—dilated cardiomyopathy	0.000257	0.00582	CcSEcCtD
Enalapril—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000254	0.00577	CcSEcCtD
Enalapril—Hearing impaired—Furosemide—dilated cardiomyopathy	0.000252	0.00571	CcSEcCtD
Enalapril—Throat sore—Lisinopril—dilated cardiomyopathy	0.000249	0.00566	CcSEcCtD
Enalapril—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.000247	0.00561	CcSEcCtD
Enalapril—Vasculitis—Furosemide—dilated cardiomyopathy	0.000245	0.00557	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000244	0.00554	CcSEcCtD
Enalapril—Renal failure—Spironolactone—dilated cardiomyopathy	0.000242	0.00549	CcSEcCtD
Enalapril—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.000239	0.00542	CcSEcCtD
Enalapril—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00023	0.00522	CcSEcCtD
Enalapril—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.000222	0.00503	CcSEcCtD
Enalapril—Urine output increased—Furosemide—dilated cardiomyopathy	0.000217	0.00491	CcSEcCtD
Enalapril—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000209	0.00474	CcSEcCtD
Enalapril—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000205	0.00464	CcSEcCtD
Enalapril—Proteinuria—Lisinopril—dilated cardiomyopathy	0.000205	0.00464	CcSEcCtD
Enalapril—Protein urine present—Lisinopril—dilated cardiomyopathy	0.000202	0.00458	CcSEcCtD
Enalapril—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000199	0.00452	CcSEcCtD
Enalapril—Fosinopril—ACE—dilated cardiomyopathy	0.000199	0.113	CrCbGaD
Enalapril—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000198	0.00449	CcSEcCtD
Enalapril—Polyuria—Furosemide—dilated cardiomyopathy	0.000198	0.00449	CcSEcCtD
Enalapril—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000198	0.00449	CcSEcCtD
Enalapril—Swelling—Furosemide—dilated cardiomyopathy	0.000197	0.00447	CcSEcCtD
Enalapril—Alopecia—Spironolactone—dilated cardiomyopathy	0.000195	0.00443	CcSEcCtD
Enalapril—Oliguria—Lisinopril—dilated cardiomyopathy	0.000195	0.00443	CcSEcCtD
Enalapril—Deafness—Furosemide—dilated cardiomyopathy	0.000194	0.00441	CcSEcCtD
Enalapril—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000194	0.0044	CcSEcCtD
Enalapril—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000193	0.00437	CcSEcCtD
Enalapril—Gout—Lisinopril—dilated cardiomyopathy	0.000192	0.00437	CcSEcCtD
Enalapril—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000191	0.00434	CcSEcCtD
Enalapril—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000185	0.0042	CcSEcCtD
Enalapril—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000184	0.00418	CcSEcCtD
Enalapril—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000184	0.00418	CcSEcCtD
Enalapril—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000182	0.00413	CcSEcCtD
Enalapril—Neck pain—Lisinopril—dilated cardiomyopathy	0.000182	0.00413	CcSEcCtD
Enalapril—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00018	0.00408	CcSEcCtD
Enalapril—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00018	0.00408	CcSEcCtD
Enalapril—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000177	0.00401	CcSEcCtD
Enalapril—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000176	0.0194	CbGpPWpGaD
Enalapril—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000175	0.00396	CcSEcCtD
Enalapril—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000175	0.00396	CcSEcCtD
Enalapril—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000172	0.00391	CcSEcCtD
Enalapril—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00017	0.00385	CcSEcCtD
Enalapril—ACE—cardiac ventricle—dilated cardiomyopathy	0.000169	0.0777	CbGeAlD
Enalapril—Irritability—Furosemide—dilated cardiomyopathy	0.000166	0.00377	CcSEcCtD
Enalapril—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000163	0.0037	CcSEcCtD
Enalapril—Perindopril—ACE—dilated cardiomyopathy	0.000162	0.092	CrCbGaD
Enalapril—Discomfort—Spironolactone—dilated cardiomyopathy	0.000162	0.00367	CcSEcCtD
Enalapril—Spirapril—ACE—dilated cardiomyopathy	0.00016	0.091	CrCbGaD
Enalapril—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00016	0.00363	CcSEcCtD
Enalapril—ACE—myocardium—dilated cardiomyopathy	0.000159	0.0731	CbGeAlD
Enalapril—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000159	0.0036	CcSEcCtD
Enalapril—Confusional state—Spironolactone—dilated cardiomyopathy	0.000158	0.00359	CcSEcCtD
Enalapril—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000157	0.00356	CcSEcCtD
Enalapril—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000157	0.00355	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000157	0.00355	CcSEcCtD
Enalapril—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000154	0.00349	CcSEcCtD
Enalapril—Moexipril—ACE—dilated cardiomyopathy	0.000154	0.0872	CrCbGaD
Enalapril—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000149	0.00338	CcSEcCtD
Enalapril—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000149	0.00337	CcSEcCtD
Enalapril—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000148	0.0163	CbGpPWpGaD
Enalapril—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000147	0.00334	CcSEcCtD
Enalapril—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000145	0.00329	CcSEcCtD
Enalapril—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000145	0.00328	CcSEcCtD
Enalapril—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000143	0.00325	CcSEcCtD
Enalapril—Quinapril—ACE—dilated cardiomyopathy	0.000143	0.0811	CrCbGaD
Enalapril—Cilazapril—ACE—dilated cardiomyopathy	0.000143	0.0811	CrCbGaD
Enalapril—Lisinopril—ACE—dilated cardiomyopathy	0.000143	0.0811	CrCbGaD
Enalapril—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000141	0.00319	CcSEcCtD
Enalapril—Somnolence—Spironolactone—dilated cardiomyopathy	0.00014	0.00317	CcSEcCtD
Enalapril—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000139	0.00315	CcSEcCtD
Enalapril—Trandolapril—ACE—dilated cardiomyopathy	0.000138	0.0785	CrCbGaD
Enalapril—Ramipril—ACE—dilated cardiomyopathy	0.000138	0.0785	CrCbGaD
Enalapril—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000138	0.00312	CcSEcCtD
Enalapril—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000137	0.00311	CcSEcCtD
Enalapril—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000136	0.00308	CcSEcCtD
Enalapril—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000135	0.00306	CcSEcCtD
Enalapril—Arthritis—Lisinopril—dilated cardiomyopathy	0.000134	0.00305	CcSEcCtD
Enalapril—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000134	0.00303	CcSEcCtD
Enalapril—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000133	0.00302	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000133	0.00301	CcSEcCtD
Enalapril—Renal failure—Furosemide—dilated cardiomyopathy	0.000132	0.00299	CcSEcCtD
Enalapril—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000131	0.00297	CcSEcCtD
Enalapril—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00013	0.00296	CcSEcCtD
Enalapril—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000129	0.00294	CcSEcCtD
Enalapril—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000129	0.00294	CcSEcCtD
Enalapril—Face oedema—Lisinopril—dilated cardiomyopathy	0.000126	0.00286	CcSEcCtD
Enalapril—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000125	0.00284	CcSEcCtD
Enalapril—Urticaria—Spironolactone—dilated cardiomyopathy	0.000125	0.00283	CcSEcCtD
Enalapril—Irritability—Lisinopril—dilated cardiomyopathy	0.000125	0.00283	CcSEcCtD
Enalapril—Benazepril—ACE—dilated cardiomyopathy	0.000124	0.0705	CrCbGaD
Enalapril—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000124	0.00282	CcSEcCtD
Enalapril—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000124	0.00282	CcSEcCtD
Enalapril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000123	0.0136	CbGpPWpGaD
Enalapril—Ataxia—Lisinopril—dilated cardiomyopathy	0.000123	0.00278	CcSEcCtD
Enalapril—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000122	0.00277	CcSEcCtD
Enalapril—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000119	0.0027	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000117	0.00267	CcSEcCtD
Enalapril—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000117	0.00267	CcSEcCtD
Enalapril—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000117	0.00265	CcSEcCtD
Enalapril—Visual impairment—Furosemide—dilated cardiomyopathy	0.000116	0.00263	CcSEcCtD
Enalapril—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000116	0.00263	CcSEcCtD
Enalapril—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000115	0.0127	CbGpPWpGaD
Enalapril—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000114	0.00258	CcSEcCtD
Enalapril—Influenza—Lisinopril—dilated cardiomyopathy	0.000113	0.00256	CcSEcCtD
Enalapril—Asthma—Lisinopril—dilated cardiomyopathy	0.000113	0.00256	CcSEcCtD
Enalapril—Tinnitus—Furosemide—dilated cardiomyopathy	0.000112	0.00255	CcSEcCtD
Enalapril—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000112	0.00253	CcSEcCtD
Enalapril—ACE—heart—dilated cardiomyopathy	0.000111	0.051	CbGeAlD
Enalapril—Pruritus—Spironolactone—dilated cardiomyopathy	0.000111	0.00252	CcSEcCtD
Enalapril—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000111	0.00252	CcSEcCtD
Enalapril—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000111	0.00251	CcSEcCtD
Enalapril—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00011	0.00249	CcSEcCtD
Enalapril—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00011	0.00249	CcSEcCtD
Enalapril—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000108	0.00246	CcSEcCtD
Enalapril—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000107	0.00244	CcSEcCtD
Enalapril—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000107	0.00244	CcSEcCtD
Enalapril—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000107	0.00243	CcSEcCtD
Enalapril—Dysuria—Lisinopril—dilated cardiomyopathy	0.000105	0.00239	CcSEcCtD
Enalapril—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000105	0.00239	CcSEcCtD
Enalapril—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000105	0.00238	CcSEcCtD
Enalapril—Erythema—Furosemide—dilated cardiomyopathy	0.000105	0.00238	CcSEcCtD
Enalapril—Dizziness—Spironolactone—dilated cardiomyopathy	0.000104	0.00236	CcSEcCtD
Enalapril—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000104	0.00236	CcSEcCtD
Enalapril—Flatulence—Furosemide—dilated cardiomyopathy	0.000103	0.00234	CcSEcCtD
Enalapril—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000103	0.00234	CcSEcCtD
Enalapril—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000103	0.00233	CcSEcCtD
Enalapril—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000102	0.00231	CcSEcCtD
Enalapril—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000101	0.00229	CcSEcCtD
Enalapril—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000101	0.00228	CcSEcCtD
Enalapril—Depression—Lisinopril—dilated cardiomyopathy	0.0001	0.00227	CcSEcCtD
Enalapril—Vomiting—Spironolactone—dilated cardiomyopathy	9.99e-05	0.00227	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	9.97e-05	0.00226	CcSEcCtD
Enalapril—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	9.91e-05	0.00225	CcSEcCtD
Enalapril—Rash—Spironolactone—dilated cardiomyopathy	9.9e-05	0.00225	CcSEcCtD
Enalapril—Dermatitis—Spironolactone—dilated cardiomyopathy	9.9e-05	0.00225	CcSEcCtD
Enalapril—Renal failure—Lisinopril—dilated cardiomyopathy	9.88e-05	0.00224	CcSEcCtD
Enalapril—Vision blurred—Furosemide—dilated cardiomyopathy	9.87e-05	0.00224	CcSEcCtD
Enalapril—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	9.86e-05	0.00224	CcSEcCtD
Enalapril—Myocardial infarction—Lisinopril—dilated cardiomyopathy	9.86e-05	0.00224	CcSEcCtD
Enalapril—Headache—Spironolactone—dilated cardiomyopathy	9.84e-05	0.00223	CcSEcCtD
Enalapril—Jaundice—Lisinopril—dilated cardiomyopathy	9.8e-05	0.00222	CcSEcCtD
Enalapril—Urinary tract infection—Lisinopril—dilated cardiomyopathy	9.77e-05	0.00222	CcSEcCtD
Enalapril—Anaemia—Furosemide—dilated cardiomyopathy	9.68e-05	0.0022	CcSEcCtD
Enalapril—Agitation—Furosemide—dilated cardiomyopathy	9.62e-05	0.00218	CcSEcCtD
Enalapril—ACE—cardiac atrium—dilated cardiomyopathy	9.51e-05	0.0436	CbGeAlD
Enalapril—Epistaxis—Lisinopril—dilated cardiomyopathy	9.48e-05	0.00215	CcSEcCtD
Enalapril—Sinusitis—Lisinopril—dilated cardiomyopathy	9.43e-05	0.00214	CcSEcCtD
Enalapril—Vertigo—Furosemide—dilated cardiomyopathy	9.41e-05	0.00213	CcSEcCtD
Enalapril—Agranulocytosis—Lisinopril—dilated cardiomyopathy	9.38e-05	0.00213	CcSEcCtD
Enalapril—Leukopenia—Furosemide—dilated cardiomyopathy	9.37e-05	0.00213	CcSEcCtD
Enalapril—Nausea—Spironolactone—dilated cardiomyopathy	9.33e-05	0.00212	CcSEcCtD
Enalapril—ACE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	9.3e-05	0.0103	CbGpPWpGaD
Enalapril—Bradycardia—Lisinopril—dilated cardiomyopathy	9.19e-05	0.00209	CcSEcCtD
Enalapril—Hepatitis—Lisinopril—dilated cardiomyopathy	9.03e-05	0.00205	CcSEcCtD
Enalapril—Pharyngitis—Lisinopril—dilated cardiomyopathy	8.96e-05	0.00203	CcSEcCtD
Enalapril—Dry mouth—Furosemide—dilated cardiomyopathy	8.72e-05	0.00198	CcSEcCtD
Enalapril—Confusional state—Furosemide—dilated cardiomyopathy	8.62e-05	0.00196	CcSEcCtD
Enalapril—Anaphylactic shock—Furosemide—dilated cardiomyopathy	8.55e-05	0.00194	CcSEcCtD
Enalapril—Erythema multiforme—Lisinopril—dilated cardiomyopathy	8.53e-05	0.00194	CcSEcCtD
Enalapril—Tinnitus—Lisinopril—dilated cardiomyopathy	8.42e-05	0.00191	CcSEcCtD
Enalapril—Shock—Furosemide—dilated cardiomyopathy	8.41e-05	0.00191	CcSEcCtD
Enalapril—Flushing—Lisinopril—dilated cardiomyopathy	8.38e-05	0.0019	CcSEcCtD
Enalapril—Thrombocytopenia—Furosemide—dilated cardiomyopathy	8.37e-05	0.0019	CcSEcCtD
Enalapril—Hyperhidrosis—Furosemide—dilated cardiomyopathy	8.26e-05	0.00187	CcSEcCtD
Enalapril—ACE—Metabolism of proteins—TAZ—dilated cardiomyopathy	8.15e-05	0.00901	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	8.15e-05	0.00901	CbGpPWpGaD
Enalapril—Anorexia—Furosemide—dilated cardiomyopathy	8.15e-05	0.00185	CcSEcCtD
Enalapril—Arrhythmia—Lisinopril—dilated cardiomyopathy	8.06e-05	0.00183	CcSEcCtD
Enalapril—Hypotension—Furosemide—dilated cardiomyopathy	7.99e-05	0.00181	CcSEcCtD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	7.98e-05	0.00882	CbGpPWpGaD
Enalapril—Alopecia—Lisinopril—dilated cardiomyopathy	7.98e-05	0.00181	CcSEcCtD
Enalapril—Erythema—Lisinopril—dilated cardiomyopathy	7.86e-05	0.00178	CcSEcCtD
Enalapril—Flatulence—Lisinopril—dilated cardiomyopathy	7.74e-05	0.00176	CcSEcCtD
Enalapril—Tension—Lisinopril—dilated cardiomyopathy	7.71e-05	0.00175	CcSEcCtD
Enalapril—Dysgeusia—Lisinopril—dilated cardiomyopathy	7.69e-05	0.00175	CcSEcCtD
Enalapril—Paraesthesia—Furosemide—dilated cardiomyopathy	7.67e-05	0.00174	CcSEcCtD
Enalapril—Nervousness—Lisinopril—dilated cardiomyopathy	7.63e-05	0.00173	CcSEcCtD
Enalapril—Back pain—Lisinopril—dilated cardiomyopathy	7.6e-05	0.00172	CcSEcCtD
Enalapril—Somnolence—Furosemide—dilated cardiomyopathy	7.6e-05	0.00172	CcSEcCtD
Enalapril—Muscle spasms—Lisinopril—dilated cardiomyopathy	7.55e-05	0.00171	CcSEcCtD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	7.54e-05	0.00833	CbGpPWpGaD
Enalapril—Decreased appetite—Furosemide—dilated cardiomyopathy	7.43e-05	0.00169	CcSEcCtD
Enalapril—Vision blurred—Lisinopril—dilated cardiomyopathy	7.4e-05	0.00168	CcSEcCtD
Enalapril—Fatigue—Furosemide—dilated cardiomyopathy	7.37e-05	0.00167	CcSEcCtD
Enalapril—Tremor—Lisinopril—dilated cardiomyopathy	7.36e-05	0.00167	CcSEcCtD
Enalapril—Constipation—Furosemide—dilated cardiomyopathy	7.31e-05	0.00166	CcSEcCtD
Enalapril—Anaemia—Lisinopril—dilated cardiomyopathy	7.26e-05	0.00165	CcSEcCtD
Enalapril—Angioedema—Lisinopril—dilated cardiomyopathy	7.18e-05	0.00163	CcSEcCtD
Enalapril—Vertigo—Lisinopril—dilated cardiomyopathy	7.06e-05	0.0016	CcSEcCtD
Enalapril—Syncope—Lisinopril—dilated cardiomyopathy	7.05e-05	0.0016	CcSEcCtD
Enalapril—Feeling abnormal—Furosemide—dilated cardiomyopathy	7.04e-05	0.0016	CcSEcCtD
Enalapril—Leukopenia—Lisinopril—dilated cardiomyopathy	7.03e-05	0.0016	CcSEcCtD
Enalapril—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	6.99e-05	0.00159	CcSEcCtD
Enalapril—Palpitations—Lisinopril—dilated cardiomyopathy	6.94e-05	0.00158	CcSEcCtD
Enalapril—Loss of consciousness—Lisinopril—dilated cardiomyopathy	6.91e-05	0.00157	CcSEcCtD
Enalapril—Cough—Lisinopril—dilated cardiomyopathy	6.86e-05	0.00156	CcSEcCtD
Enalapril—Urticaria—Furosemide—dilated cardiomyopathy	6.79e-05	0.00154	CcSEcCtD
Enalapril—Abdominal pain—Furosemide—dilated cardiomyopathy	6.76e-05	0.00153	CcSEcCtD
Enalapril—Body temperature increased—Furosemide—dilated cardiomyopathy	6.76e-05	0.00153	CcSEcCtD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	6.71e-05	0.00741	CbGpPWpGaD
Enalapril—Myalgia—Lisinopril—dilated cardiomyopathy	6.69e-05	0.00152	CcSEcCtD
Enalapril—Arthralgia—Lisinopril—dilated cardiomyopathy	6.69e-05	0.00152	CcSEcCtD
Enalapril—Chest pain—Lisinopril—dilated cardiomyopathy	6.69e-05	0.00152	CcSEcCtD
Enalapril—Discomfort—Lisinopril—dilated cardiomyopathy	6.61e-05	0.0015	CcSEcCtD
Enalapril—Dry mouth—Lisinopril—dilated cardiomyopathy	6.54e-05	0.00148	CcSEcCtD
Enalapril—Confusional state—Lisinopril—dilated cardiomyopathy	6.47e-05	0.00147	CcSEcCtD
Enalapril—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	6.41e-05	0.00146	CcSEcCtD
Enalapril—Oedema—Lisinopril—dilated cardiomyopathy	6.41e-05	0.00146	CcSEcCtD
Enalapril—Shock—Lisinopril—dilated cardiomyopathy	6.31e-05	0.00143	CcSEcCtD
Enalapril—Hypersensitivity—Furosemide—dilated cardiomyopathy	6.3e-05	0.00143	CcSEcCtD
Enalapril—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	6.28e-05	0.00142	CcSEcCtD
Enalapril—Tachycardia—Lisinopril—dilated cardiomyopathy	6.26e-05	0.00142	CcSEcCtD
Enalapril—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	6.2e-05	0.00141	CcSEcCtD
Enalapril—Asthenia—Furosemide—dilated cardiomyopathy	6.13e-05	0.00139	CcSEcCtD
Enalapril—Anorexia—Lisinopril—dilated cardiomyopathy	6.11e-05	0.00139	CcSEcCtD
Enalapril—Pruritus—Furosemide—dilated cardiomyopathy	6.05e-05	0.00137	CcSEcCtD
Enalapril—Hypotension—Lisinopril—dilated cardiomyopathy	5.99e-05	0.00136	CcSEcCtD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	5.95e-05	0.00658	CbGpPWpGaD
Enalapril—Diarrhoea—Furosemide—dilated cardiomyopathy	5.85e-05	0.00133	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	5.84e-05	0.00133	CcSEcCtD
Enalapril—Insomnia—Lisinopril—dilated cardiomyopathy	5.8e-05	0.00132	CcSEcCtD
Enalapril—Paraesthesia—Lisinopril—dilated cardiomyopathy	5.76e-05	0.00131	CcSEcCtD
Enalapril—Dyspnoea—Lisinopril—dilated cardiomyopathy	5.72e-05	0.0013	CcSEcCtD
Enalapril—Somnolence—Lisinopril—dilated cardiomyopathy	5.7e-05	0.00129	CcSEcCtD
Enalapril—Dizziness—Furosemide—dilated cardiomyopathy	5.65e-05	0.00128	CcSEcCtD
Enalapril—Dyspepsia—Lisinopril—dilated cardiomyopathy	5.64e-05	0.00128	CcSEcCtD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	5.6e-05	0.00618	CbGpPWpGaD
Enalapril—Decreased appetite—Lisinopril—dilated cardiomyopathy	5.57e-05	0.00126	CcSEcCtD
Enalapril—Fatigue—Lisinopril—dilated cardiomyopathy	5.53e-05	0.00125	CcSEcCtD
Enalapril—Constipation—Lisinopril—dilated cardiomyopathy	5.48e-05	0.00124	CcSEcCtD
Enalapril—Vomiting—Furosemide—dilated cardiomyopathy	5.43e-05	0.00123	CcSEcCtD
Enalapril—Rash—Furosemide—dilated cardiomyopathy	5.39e-05	0.00122	CcSEcCtD
Enalapril—Dermatitis—Furosemide—dilated cardiomyopathy	5.38e-05	0.00122	CcSEcCtD
Enalapril—Headache—Furosemide—dilated cardiomyopathy	5.35e-05	0.00121	CcSEcCtD
Enalapril—Feeling abnormal—Lisinopril—dilated cardiomyopathy	5.28e-05	0.0012	CcSEcCtD
Enalapril—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	5.24e-05	0.00119	CcSEcCtD
Enalapril—Urticaria—Lisinopril—dilated cardiomyopathy	5.09e-05	0.00116	CcSEcCtD
Enalapril—Nausea—Furosemide—dilated cardiomyopathy	5.08e-05	0.00115	CcSEcCtD
Enalapril—Body temperature increased—Lisinopril—dilated cardiomyopathy	5.07e-05	0.00115	CcSEcCtD
Enalapril—Abdominal pain—Lisinopril—dilated cardiomyopathy	5.07e-05	0.00115	CcSEcCtD
Enalapril—Hypersensitivity—Lisinopril—dilated cardiomyopathy	4.72e-05	0.00107	CcSEcCtD
Enalapril—Asthenia—Lisinopril—dilated cardiomyopathy	4.6e-05	0.00104	CcSEcCtD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.59e-05	0.00507	CbGpPWpGaD
Enalapril—Pruritus—Lisinopril—dilated cardiomyopathy	4.54e-05	0.00103	CcSEcCtD
Enalapril—Diarrhoea—Lisinopril—dilated cardiomyopathy	4.39e-05	0.000996	CcSEcCtD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.32e-05	0.00477	CbGpPWpGaD
Enalapril—Dizziness—Lisinopril—dilated cardiomyopathy	4.24e-05	0.000962	CcSEcCtD
Enalapril—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.17e-05	0.00461	CbGpPWpGaD
Enalapril—Vomiting—Lisinopril—dilated cardiomyopathy	4.08e-05	0.000925	CcSEcCtD
Enalapril—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.05e-05	0.00448	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.05e-05	0.00448	CbGpPWpGaD
Enalapril—Rash—Lisinopril—dilated cardiomyopathy	4.04e-05	0.000917	CcSEcCtD
Enalapril—Dermatitis—Lisinopril—dilated cardiomyopathy	4.04e-05	0.000917	CcSEcCtD
Enalapril—Headache—Lisinopril—dilated cardiomyopathy	4.02e-05	0.000912	CcSEcCtD
Enalapril—SLC15A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.94e-05	0.00435	CbGpPWpGaD
Enalapril—ABCB1—heart—dilated cardiomyopathy	3.91e-05	0.018	CbGeAlD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.83e-05	0.00423	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.83e-05	0.00423	CbGpPWpGaD
Enalapril—Nausea—Lisinopril—dilated cardiomyopathy	3.81e-05	0.000864	CcSEcCtD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.77e-05	0.00416	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.56e-05	0.00394	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.5e-05	0.00387	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.41e-05	0.00377	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.41e-05	0.00377	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	3.26e-05	0.0036	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—LMNA—dilated cardiomyopathy	3.21e-05	0.00355	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.17e-05	0.0035	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.11e-05	0.00344	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.03e-05	0.00334	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.03e-05	0.00334	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.92e-05	0.00323	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.84e-05	0.00314	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.84e-05	0.00314	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.81e-05	0.00311	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	2.75e-05	0.00303	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.64e-05	0.00292	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	2.3e-05	0.00254	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	2.14e-05	0.00236	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	2.06e-05	0.00228	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.04e-05	0.00226	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	1.92e-05	0.00212	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—AGT—dilated cardiomyopathy	1.76e-05	0.00194	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	1.74e-05	0.00192	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.33e-05	0.00147	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.3e-05	0.00143	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.3e-05	0.00143	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.2e-05	0.00133	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.06e-05	0.00117	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.06e-05	0.00117	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.03e-05	0.00114	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.02e-05	0.00112	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	9.98e-06	0.0011	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.3e-06	0.00103	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	8.76e-06	0.000967	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	8.75e-06	0.000967	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	8.23e-06	0.000909	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.22e-06	0.000908	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.77e-06	0.000859	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	7.44e-06	0.000822	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.91e-06	0.000764	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	6.62e-06	0.000731	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.14e-06	0.000678	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.77e-06	0.000637	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	5.39e-06	0.000596	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	5.07e-06	0.00056	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	4.72e-06	0.000522	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	4.6e-06	0.000508	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	4.59e-06	0.000507	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.54e-06	0.000501	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.32e-06	0.000477	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	4.14e-06	0.000458	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.63e-06	0.00029	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.02e-06	0.000223	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.97e-06	0.000218	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.77e-06	0.000196	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.25e-06	0.000138	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.21e-06	0.000134	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.09e-06	0.000121	CbGpPWpGaD
